Literature DB >> 7115311

Kinetics of Vibrio cholerae sialidase action on gangliosidic substrates at different supramolecular-organizational levels.

B Venerando, B Cestaro, A Fiorilli, R Ghidoni, A Preti, G Tettamanti.   

Abstract

G(d1a), G(d1b) and G(t1b) gangliosides were dispersed in the following membrane-mimicking systems: (a) homogeneous micelles; (b) mixed micelles with G(m1) ganglioside (which is resistant to the enzyme action), Triton X-100 or bovine serum albumin; (c) small unilamellar vesicles of egg phosphatidylcholine. The effect of dispersion on sialic acid release by Vibrio cholerae sialidase was studied. As reference substrates freely interacting with the enzyme the lipid-free carbohydrates of G(d1a) and 3'-sialosyl-lactose were employed. The apparent V(max.) of the enzyme was, with all the gangliosides, dependent on the type of ganglioside dispersion. It was lowest for homogeneous micelles and mixed micelles with ganglioside G(m1), and increased about 6-fold for ganglioside/bovine serum albumin lipoprotein micelles, 15-fold for mixed-ganglioside/Triton X-100 micelles (optimal molar ratio 1:7.5) and 30-fold for phosphatidylcholine vesicles containing 2.5 mol% ganglioside (this proportion was optimal for enzyme activity on the vesicles). For ganglioside G(d1a), the activity on Triton X-100 mixed micelles and on mixed vesicles was even greater (3- and 6-fold respectively) than that displayed on G(d1a) lipid-free carbohydrate. With each of the used gangliosides the apparent K(m) values were very similar values for homogeneous micelles and vesicular dispersions, but showed marked increases for Triton X-100 mixed micelles, approaching the values exhibited by reference oligosaccharides. Triton X-100 micelles and phosphatidylcholine vesicles did not appreciably alter the kinetics of sialidase action on 3'-sialosyl-lactose and on G(d1a) lipid-free carbohydrate, indicating that the above effects are dependent on the intrinsic characteristics of the membrane-like systems containing gangliosides.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115311      PMCID: PMC1158290          DOI: 10.1042/bj2030735

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  THE ACTION OF NEURAMINIDASE FROM CLOSTRIDIUM PERFRINGENS ON GANGLIOSIDES.

Authors:  R M BURTON
Journal:  J Neurochem       Date:  1963-07       Impact factor: 5.372

2.  Hydrolysis of phosphatidylcholine liposomes by pancreatic phospholipase A2 at the transition temperature.

Authors:  J A Op den Kamp; J de Gier; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1974-04-29

3.  A new procedure for the extraction, purification and fractionation of brain gangliosides.

Authors:  G Tettamanti; F Bonali; S Marchesini; V Zambotti
Journal:  Biochim Biophys Acta       Date:  1973-01-19

4.  The isolation of sialyllactosides with the aid of gel filtration.

Authors:  R Ohman; O Hygstedt
Journal:  Anal Biochem       Date:  1968-06       Impact factor: 3.365

5.  Viral and bacterial neuraminidases.

Authors:  R Drzeniek
Journal:  Curr Top Microbiol Immunol       Date:  1972       Impact factor: 4.291

6.  Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers.

Authors:  R A Demel; W S Geurts van Kessel; R F Zwaal; B Roelofsen; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1975-09-16

7.  Critical micelle concentrations of gangliosides.

Authors:  S Formisano; M L Johnson; G Lee; S M Aloj; H Edelhoch
Journal:  Biochemistry       Date:  1979-03-20       Impact factor: 3.162

8.  Hydrolysis of di- and trisialo gangliosides in micellar and liposomal dispersion by bacterial neuraminidases.

Authors:  B Cestaro; Y Barenholz; S Gatt
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

9.  Optimal conditions for the assay of fibroblast neuraminidase with different natural substrates.

Authors:  L Caimi; A Lombardo; A Preti; U Wiesmann; G Tettamanti
Journal:  Biochim Biophys Acta       Date:  1979-11-09

10.  Membrane-bound neuraminidase from calf brain: regulation of oligosialoganglioside degradation by membrane fluidity and membrane components.

Authors:  K Sandhoff; B Pallmann
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

View more
  6 in total

1.  Terminal sialic acids are an important determinant of pulmonary endothelial barrier integrity.

Authors:  Donna L Cioffi; Subha Pandey; Diego F Alvarez; Eugene A Cioffi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-02       Impact factor: 5.464

2.  Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection.

Authors:  Fiona E Fleming; Raphael Böhm; Vi T Dang; Gavan Holloway; Thomas Haselhorst; Paul D Madge; Jaigeeth Deveryshetty; Xing Yu; Helen Blanchard; Mark von Itzstein; Barbara S Coulson
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Investigation of substrate specificity of sialidases with membrane mimetic glycoconjugates.

Authors:  Sonia Tomar; Xue-Long Sun
Journal:  Glycoconj J       Date:  2019-12-04       Impact factor: 2.916

4.  Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System.

Authors:  Massimo Aureli; Laura Mauri; Emma Veronica Carsana; Dorina Dobi; Silvia Breviario; Giulia Lunghi; Sandro Sonnino
Journal:  Adv Neurobiol       Date:  2023

5.  Synthesis and chemical characterization of several perfluorinated sialic acid glycals and evaluation of their in vitro antiviral activity against Newcastle disease virus.

Authors:  P Rota; N Papini; P La Rocca; M Montefiori; F Cirillo; M Piccoli; R Scurati; L Olsen; P Allevi; L Anastasia
Journal:  Medchemcomm       Date:  2017-06-05       Impact factor: 3.597

Review 6.  Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.

Authors:  Elena Chiricozzi; Erika Di Biase; Giulia Lunghi; Maria Fazzari; Nicoletta Loberto; Massimo Aureli; Laura Mauri; Sandro Sonnino
Journal:  Glycoconj J       Date:  2021-02-23       Impact factor: 2.916

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.